The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: -0.25 (-0.78%)
Spread: 0.50 (1.587%)
Open: 31.75
High: 31.75
Low: 31.75
Prev. Close: 32.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Royalty finance agreement LOI and secured loan

14 Jun 2018 07:01

RNS Number : 3408R
Duke Royalty Limited
14 June 2018
 

14 June 2018

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

LOI signed for fifth Royalty Investment and £3.5m secured loan

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has signed an exclusive Letter of Intent ("LOI") for a fifth royalty investment. The total planned consideration for this near-term investment opportunity is US$3.5 million.

The target Royalty Partner ("PartnerCo") was founded in the 1950s and represents the largest US provider of legal information that is solely focussed on serving the law enforcement market.

PartnerCo's publications include enforcement manuals, code books and field guides that highlight legislative changes and guidelines.

PartnerCo's mission is to help the law enforcement community be more efficient by providing them easy access to the latest laws, rules, and regulations and by equipping them with the tools to educate and train officers, management, the courts and the citizens.

The investment opportunity meets all of Duke's stated criteria:

· Long-standing, profitable operating history

· Experienced senior management team with high equity ownership

· Initial cash-on-cash yield of more than 13 per cent. per annum via monthly payments immediately post investment

· 40 year secured financing - distributions to be adjusted annually to reflect PartnerCo's revenue growth

This investment opportunity is well advanced but still subject to final due diligence and definitive documentation. It is expected that this transaction will be completed in the coming weeks, with a possible initial tranche of capital being provided during June 2018.

The LOI also includes the terms to scale up Duke's investment up to U$7.0 million. PartnerCo has additional acquisition targets which Duke has agreed to finance through subsequent tranches on the same terms, subject to PartnerCo maintaining Duke's investment criteria post-acquisition.

In order to position itself to finance the planned investment into PartnerCo, Duke has secured a loan of £3.5m from a non-related third party. The summary terms of this loan are:

· £3.5m secured loan with expiry date of 30 June 2019

· 9% per annum interest rate until 31 December 2018, rising to 12% per annum for the final six-month period ending June 30th 2019

· 2% drawdown fee

· Automatic repayment in the event of the closure of an equity issue of more than £3.5m and/or in the event that the £3.5m loan becomes greater than 20% of the NAV of Duke

Neil Johnson, CEO of Duke Royalty, said:

"Duke's near term goal is to diversify its portfolio through the addition of new Royalty Partners and this accretive LOI has allowed us to maintain momentum towards achieving this.

"Therefore, we are pleased to have gained exclusivity over our fifth Royalty Partner, a unique business with compelling long term prospects and an impressive management team, by securing a modest amount of leverage to demonstrate that Duke has the capital on its balance sheet.

"We are accumulating a royalty portfolio which provides robust, predictable, long term returns to shareholders, targeting a high single-digit yield in 2018. With this in mind, I am pleased to report that Duke's royalty pipeline continues to grow and we look forward to updating the market in due course."

 

***ENDS***

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson/ Charlie Cannon-Brookes

 

+44 (0) 1481 741 240

Grant Thornton UK LLP 

(Nominated Adviser)

Colin Aaronson/ Samantha

Harrison

 

+44 (0) 20 7383 5100

 

Cenkos Securities plc 

(Joint Broker)

 

Julian Morse/ Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited

(Joint Broker)

 

Peter Krens/ Edward Haig-Thomas

 

+44 (0) 20 3167 7222

Redleaf Communications

(PR)

 

Elisabeth Cowell/ Robin Tozer/ Ian Silvera

+44 (0) 20 3757 6880

Dukeroyalty@redleafpr.com

 

About Duke Royalty

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
LOIDGGDLXUBBGIX
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.